ViroPharma, Inc. (NASDAQ:VPHM)

CAPS Rating: 4 out of 5

A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.

Recs

0
Player Avatar Hotpicks101 (29.34) Submitted: 1/6/2011 12:27:10 PM : Underperform Start Price: $17.68 VPHM Score: -9.94

zz and ultra.

Featured Broker Partners


Advertisement